Surging Demand Drives Growth In The Fetal Bovine Serum Market: Strengthening the Growth Trajectory of the Fetal Bovine Serum Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Fetal Bovine Serum Market Through 2025?
The market size of fetal bovine serum has seen consistent growth in the past few years. The projected growth is from $1.02 billion in 2024 to $1.06 billion in 2025, with a compound annual growth rate (CAGR) of 4.6%. The expansion of the biopharmaceutical industry, an increase in cell-based therapies, and requirements for quality and consistency have all contributed to the growth seen in the historical period.

What's the Projected Size of the Global Fetal Bovine Serum Market by 2029?
In the coming years, the market size of fetal bovine serum is predicted to witness robust growth, reaching to "$1.31 billion in 2029" with a compound annual growth rate (CAGR) of 5.4%. This surge during the forecast period is due to the rising adoption of cell therapies, the development of innovative therapeutics, focus on alternatives that do not involve animals, and comprehensive supplier-customer relationships. Several trends expected during the forecast period comprise prioritizing quality and traceability, international collaboration and partnerships, strategic amalgamations and acquisitions, personalized fetal bovine serum goods, regulatory compliance, and ethical sourcing.

View the full report here:
https://www.thebusinessresearchcompany.com/report/fetal-bovine-serum-global-market-report

Top Growth Drivers in the Fetal Bovine Serum Industry: What's Accelerating the Market?
The fetal bovine serum market's growth is anticipated to be fuelled by the rising demand for biopharmaceuticals in the projected timeframe. Biopharmaceuticals are medicinal substances obtained from biological origins such as animals, humans, and microbes through biotechnological processes. Fetal bovine serum (FBS) is the most frequently used alternative for animal cell culture media. Most of the cell culture needs in biologics research are met by FBS, which is extensively used by pharmaceutical companies, diagnostic labs, and researchers. In 2022, ProClinical Limited, a lifesciences consulting and service firm located in the UK, reported that its pharmaceutical and vaccine segments' sales amounted to US$36.15mn, representing an 11% YOY increase. Consequently, the fetal bovine serum market experiences significant growth driven by the increasing demand for biopharmaceuticals.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4109&type=smp

What Are the Key Trends Driving Fetal Bovine Serum Market Growth?
The escalating partnerships between businesses and research institutions are becoming a pivotal trend in the fetal bovine serum market. The main purpose of such collaborations is to boost production capacities, expand market presence, and innovate new products. For example, GE Healthcare, a US-based company, teamed up with Oritain, a New Zealand-based company, to develop a unique test that can verify the country of origin of Fetal Bovine Serum (FBS). This is crucial for biomanufacturing firms, as FBS used in various countries carries different levels of risk for virus contamination.

What Are the Main Segments in the Fetal Bovine Serum Market?
The fetal bovine serum market covered in this report is segmented -

1) By Product: Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Other Products
2) By Application: Drug Discovery, Cell Culture Media, In Vitro Fertilization, Human And Animal Vaccine Production, Diagnostics, Other Applications
3) By End-User: Research And Academic Institutes, Biotechnology And Pharmaceutical Industry, Other End-Users

Subsegments:
1) By Charcoal Stripped: Standard Charcoal Stripped FBS, Heat-Inactivated Charcoal Stripped FBS
2) By Chromatographic: Ion Exchange Chromatography Purified FBS, Affinity Chromatography Purified FBS
3) By Dialyzed Fetal Bovine Serum: Standard Dialyzed FBS, Heat-Inactivated Dialyzed FBS
4) By Exosome Depleted: Standard Exosome Depleted FBS, Heat-Inactivated Exosome Depleted FBS
5) By Stem Cell: Stem Cell Grade FBS, Knockout Serum Replacement
6) By Other Products: Serum from Specific Animal Breeds, Custom-Processed FBS

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=4109&type=smp

Which Top Companies are Driving Growth in the Fetal Bovine Serum Market?
Major companies operating in the fetal bovine serum market include Thermo Fisher Scientific Inc., Merck KGaA, Corning Incorporated, Cytiva, VWR International, Sartorius AG, Bio-Techne Corporation, Atlas Biologicals Inc., R&D Systems Inc., Atlanta Biologicals Inc., Cyagen Biosciences, GenClone Inc., Gemini Bio-Products, Access Biologicals LLC, Nucleus Biologics, ZenBio Inc., Biowest, Bovogen Biologicals Pty Ltd., TCS Biosciences Ltd., J R Scientific Inc., Rocky Mountain Biologicals Inc., Tissue Culture Biologicals, Moregate Biotech, Cell Applications Inc., Altogen Biosystems, Axil Scientific Pte Ltd., Animal Technologies Inc., PAN- Biotech, PAA Laboratories GmbH, Peak Serum Inc.

Which Regions Will Dominate the Fetal Bovine Serum Market Through 2029?
North America was the largest region in the fetal bovine serum market in 2024. Asia-Pacific recorded the fastest growth during the forecast period. The regions covered in the fetal bovine serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=4109

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.